Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Recent Offerings Show Some Companies Were Ready For The Government Shutdown

Jan 16 2019

• By Mandy Jackson

Finance Watch

Related Content

Novartis Goes Big On Gene Therapy With $8.7bn AveXis Acquisition

Apr 09 2018

ANI eyes more deals to follow WellSpring

Nov 16 2018

Deal Watch: Gilead Ups Its Investment In CAR-T With Cell Design Buy

Dec 07 2017

'Totality Of Data' Make A Case For Luspatercept In Beta-Thalassemia, MDS

Dec 03 2018

J.P. Morgan Notebook Day 1: Pfizer, Gilead, Alnylam, Novartis, Sarepta, Deal Trends And Cell Therapy Challenges

Jan 08 2019

J.P. Morgan 2019: Industry Throws A Bonanza, With An Elephant In The Room

Jan 10 2019

J.P. Morgan 2019: Biopharma Sentiment Soars As Deal And Financing Optimism Abounds

Jan 14 2019

The Gene Therapies Are Coming – And So Are New Ways To Pay For Them

Jan 15 2019

Aimmune Accelerates Commercial Planning For Peanut Allergy Drug

Feb 21 2018

Celgene Seeks CAR-T Leadership, Hematology Diversification With Juno Buy

Jan 23 2018

Immune-Focused Discovery Firm Alpine Goes Public With Nivalis Merger

Apr 19 2017

Related Companies

Alnylam Pharmaceuticals Inc.

Acceleron Pharma, Inc.

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Novartis AG

AveXis, Inc.

ANI Pharmaceuticals, Inc.

Aimmune Therapeutics, Inc.

Rezolute, Inc.

Handok

Genexine Inc.

XOMA Royalty Corporation

Windtree Therapeutics, Inc.

Lee's Pharmaceutical Holdings Limited

Alpine Immune Sciences Inc.

Nivalis Therapeutics, Inc.

Additional Topics

Financing Business Strategies Regenerative Medicine Deals Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window